silver has been researched along with sulfadiazine in 85 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 66 (77.65) | 18.7374 |
1990's | 4 (4.71) | 18.2507 |
2000's | 1 (1.18) | 29.6817 |
2010's | 9 (10.59) | 24.3611 |
2020's | 5 (5.88) | 2.80 |
Authors | Studies |
---|---|
Nesbitt, RU; Sandmann, BJ | 1 |
Weinstein, L | 1 |
Chang, TW | 1 |
Drake, DJ; Froese, EH | 1 |
Clarke, AM | 1 |
Wysor, MS | 2 |
Catania, PN; King, JC | 1 |
Fox, CL; Modak, SM; Stanford, JW | 1 |
Charoonsmith, T; Satienchoke, M; Tiewtranonda, P; Tittiranonda, T | 1 |
Fox, CL | 2 |
Mason, AD; Pruitt, BA; Warden, GD | 1 |
Chang, TW; Weinstein, L | 2 |
Carr, HS; Rosenkranz, HS | 2 |
Rosendranz, HS; Speck, WT | 1 |
Coward, JE; Rosendranz, HS | 1 |
Henderson, RN | 1 |
Montes, LF; Myers, RP | 1 |
Angebranndt, MJ; Laserna, JJ; Sutherland, WS; Winefordner, JD | 1 |
Belviranli, M; Duman, S; Gurbilek, M; Karahan, O; Kartal, A; Sahin, M; Tatkan, Y; Temur, S | 1 |
Achauer, B; Cruse, W; Deitch, EA; Finley, R; Heimbach, D; Jordan, M; Kahn, A; Matsuda, T; Salisbury, R; Sittig, K | 1 |
Benvenisty, A; Fox, CL; Modak, SM; Nowygrod, R; Reemstmau, K; Sampath, L | 1 |
Burchett, J; Clarke, AM; Keogh, J; Nixon, M; Solomon, J | 2 |
Bull, JP; Cason, JS; Davies, JW; Ford, PM; Jackson, DM; Lilly, HA; Lowbury, EJ | 1 |
Rosenkranz, HS; Wlodkowski, TJ | 1 |
Rosenkranz, HS; Speck, WT | 1 |
Fox, CL; Modak, SM | 2 |
Wysor, MS; Zollinhofer, RE | 2 |
Law, EJ; MacMillian, BG; Popp, MB | 1 |
Carr, HS; Coward, JE; Rosenkranz, HS | 2 |
Krizek, TJ; Robson, MC; Schaerf, RH | 1 |
Groskin, MG; Krizek, TJ; Robson, MC | 1 |
Munster, AM; Pruitt, BA | 1 |
Dietrich, FE; Oehlert, W; Zimmermann, WE | 1 |
Fox, CL; Shimizu, Y; Tokumaru, T | 1 |
Ballin, JC | 1 |
Donald, M | 1 |
Dickinson, SJ | 1 |
Flagg, SV; Jabaley, ME; Krizek, TJ; Wolfort, FG | 1 |
McDougall, IA | 1 |
Rosenkranz, HS; Rosenkranz, S | 1 |
Burleson, R; Eiseman, B | 1 |
Carr, HS; Rosenkranz, HS; Wlodkowski, TJ | 1 |
Carr, HS; Coward, JE; Rosenkranz, HS; Wlodkowski, TJ | 1 |
Reid, WH | 1 |
Nesbitt, RU; Sandmann, BJ; Sandmann, RA | 1 |
Fox, CL; Sampath, AC; Stanford, JW | 1 |
Grabowski, BF; Haney, WG | 1 |
Headley, BJ; Krizek, TJ; Robson, MC | 1 |
Cossman, DV; Krizek, TJ | 1 |
Grossman, AR | 1 |
Converse, JM; Flagg, SV; Rapaport, FT | 1 |
Fox, CL; Rappole, BW; Stanford, W | 2 |
Fox, CL; Fox, P; Friedlaender, J; Modak, S; Stanford, J | 1 |
Hirakawa, K | 1 |
Nathan, P; Robb, EC | 1 |
Bach, A; Böhrer, H; Geiss, HK; Martin, E; Motsch, J; Sonntag, HG | 1 |
Gamelli, RL; Hoppensteadt, D; Kowal-Vern, A; Sharp-Pucci, M; Walenga, JM | 1 |
Hollinger, MA | 1 |
Lansdown, AB | 1 |
Chen, P; Cheng, P; Li, L; Sun, H | 1 |
Abendroth, P; Behrens, P; Bleich, A; Bradel, S; Brandes, G; Duda, F; Ehlert, N; Esser, KH; Heemeier, T; Lenarz, T; Prenzler, NK | 1 |
Mavrodinova, V; Mihály, J; Popova, M; Szegedi, Á; Yoncheva, K | 1 |
Duffy, P; Kennedy, R; McMahon, S; Tai, H; Vasquez, JM; Wall, JG; Wang, W | 1 |
Dadfarnia, S; Fattahi, MR; Haji Shabani, AM; Kazemi, E; Khodaveisi, J | 1 |
Bhattacharjee, K; Joshi, SR; Mitra, S; Rajkumar, I; Sonu, VK | 1 |
Chen, S; Cui, J; Ma, X; Shao, H; Zhan, J | 1 |
Ghate, V; Kodoth, A; Kurowska, A; Lewis, SA; Prakash, B; Shah, A; Vishalakshi, B | 1 |
Afsharipour, R; Dadfarnia, S; Haji Shabani, AM; Kazemi, E | 1 |
Bello, MG; Guo, T; Li, H; Luo, T; Mittal, P; Regmi, B; Ren, X; Shakya, S; Wu, L; Zhang, J; Zhu, W | 1 |
Cazaubon, Y; Cohen, B; Colonna, G; Darrouzain, F; Deguigne, M; Leccia, F; Lelievre, B; Tellier, AC | 1 |
He, C; Leng, X; Liu, N; Liu, X; Long, Y; Miao, Y; Ning, X; Wu, T; Zhou, Z | 1 |
Goga, M; Harvanová, J; Megyesi, ŠL; Mudroň, P; Mudroňová, D; Rendošová, M; Sovová, S; Tkáčiková, Ľ; Vargová, Z | 1 |
4 review(s) available for silver and sulfadiazine
Article | Year |
---|---|
Recent advances in the management of burns.
Topics: Bandages; Burns; Duodenal Obstruction; Duodenal Ulcer; Gentamicins; Humans; Methods; Ointments; Parenteral Nutrition; Patient Care Team; Resuscitation; Silver; Silver Nitrate; Simplexvirus; Skin Transplantation; Solutions; Sulfadiazine; Sulfanilamides; Sulfonamides; Toluene; Transplantation, Homologous | 1971 |
Toxicological aspects of topical silver pharmaceuticals.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Burns; Drug Combinations; Electrodes; Humans; Immunity, Cellular; Iontophoresis; Silver; Skin Absorption; Sulfadiazine; Wound Healing | 1996 |
Silver in health care: antimicrobial effects and safety in use.
Topics: Administration, Cutaneous; Anti-Infective Agents; Humans; Silver; Silver Nitrate; Skin; Skin Care; Sulfadiazine; Textiles; Wound Healing | 2006 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
3 trial(s) available for silver and sulfadiazine
Article | Year |
---|---|
Results of a multicenter outpatient burn study on the safety and efficacy of Dimac-SSD, a new delivery system for silver sulfadiazine.
Topics: Acrylates; Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Bandages; Burns; Child; Child, Preschool; Dimethyl Sulfoxide; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Male; Methacrylates; Middle Aged; Multicenter Studies as Topic; Polyethylene Glycols; Prospective Studies; Silver; Silver Sulfadiazine; Sulfadiazine; Wound Infection | 1989 |
Alternative forms of local treatment for burns.
Topics: Acetates; Adolescent; Adult; Aged; Air; Body Temperature; Burns; Child; Child, Preschool; Enterobacteriaceae; Hot Temperature; Humans; Humidity; Infant; Infant, Newborn; Middle Aged; Ointments; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Silver; Silver Nitrate; Staphylococcal Infections; Staphylococcus; Sulfadiazine; Sulfonamides; Time Factors; Toluene; Wound Infection | 1971 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
79 other study(ies) available for silver and sulfadiazine
Article | Year |
---|---|
Solubility studies of silver sulfadiazine.
Topics: Chemical Phenomena; Chemistry; Chemistry, Pharmaceutical; Hydrogen-Ion Concentration; Mathematics; Silver; Silver Sulfadiazine; Solubility; Sulfadiazine | 1977 |
In vitro activity of silver sulfadiazine against Herpesvirus hominis.
Topics: Amnion; Animals; Cattle; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Rabbits; Silver; Silver Nitrate; Simplexvirus; Sulfadiazine; Time Factors | 1975 |
Antiherpesviral activity of silver sulfadiazine.
Topics: Humans; Keratitis, Dendritic; Silver; Silver Nitrate; Simplexvirus; Sulfadiazine | 1975 |
The preparation and invivo use of silver sulphadiazine cream for treatment of burns infected with Pseudomonas aeruginosa.
Topics: Burns; Humans; Ointments; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Sulfadiazine; Wound Infection | 1975 |
Topical use of silver sulphadiazine and chlorhexidine in the prevention of infection in thermal injuries.
Topics: Administration, Topical; Anti-Infective Agents, Local; Bacteria; Biguanides; Burns; Child; Chlorhexidine; Humans; Pseudomonas aeruginosa; Silver; Skin Diseases, Infectious; Staphylococcus; Sulfadiazine | 1975 |
Orally-administered silver sulfadiazine: chemotherapy and toxicology in CF-1 mice; Plasmodium berghei (Malaria) and Pseudomonas aeruginosa.
Topics: Administration, Oral; Animals; Injections, Subcutaneous; Malaria; Mice; Mice, Inbred Strains; Plasmodium berghei; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Sulfadiazine | 1975 |
Inhibition of supraeschar and subeschar Pseudomonas infection by silver sulfadiazine dry foam.
Topics: Animals; Burns; Guinea Pigs; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Sulfadiazine; Time Factors | 1975 |
Zinc sulfadiazine for topical therapy of pseudomonas infection in burns.
Topics: Administration, Topical; Animals; Blood Proteins; Burns; DNA; Eating; Lethal Dose 50; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Silver; Sulfadiazine; Wound Healing; Zinc | 1976 |
Silver sulfadiazine in the treatment of burns.
Topics: Administration, Topical; Burns; Humans; Silver; Sulfadiazine | 1976 |
Silver sulfadiazine for control of burn wound infections.
Topics: Adult; Aged; Bandages; Burns; Child; Humans; Middle Aged; Ointments; Silver; Skin Transplantation; Sulfadiazine; Tendon Transfer; Transplantation, Autologous; Wound Infection | 1975 |
Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the management of thermal injuries.
Topics: Administration, Topical; Burns; Chemotaxis; Cytological Techniques; Hot Temperature; Humans; In Vitro Techniques; Leukocytes; Serum Albumin; Silver; Silver Nitrate; Sulfadiazine; Sulfonamides; Tosyl Compounds; Wound Infection | 1975 |
Inactivation of Treponema pallidum by silver sulfadiazine.
Topics: Animals; Male; Rabbits; Silver; Sulfadiazine; Time Factors; Treponema pallidum; Treponemal Infections | 1975 |
R factor in Enterobacter cloacae resistant to silver sulfadiazine.
Topics: Ampicillin; Carbenicillin; Enterobacteriaceae; Escherichia coli; Kanamycin; Penicillin Resistance; R Factors; Silver; Sulfadiazine | 1975 |
Antimalarials: screening of (orally administered) silver solfonamides against Plasmodium berghei.
Topics: Administration, Oral; Animals; Antimalarials; Drug Evaluation, Preclinical; Malaria; Mice; Plasmodium berghei; Silver; Sulfadiazine; Sulfonamides | 1975 |
In vitro study on the effects of silver sulfadiazine on bilirubin binding.
Topics: Adult; Bilirubin; Caffeine; Chromatography, Gel; Humans; Jaundice; Protein Binding; Serum Albumin; Silver; Sulfadiazine | 1975 |
Electron microscopic appearance of silver sulfadiazine-treated Enterobacter cloacae.
Topics: Cell Wall; Cytoplasm; Enterobacteriaceae; Microscopy, Electron; Silver; Sulfadiazine | 1975 |
Letter:Silver sulfadiazine.
Topics: Burns; Humans; Mafenide; Placebos; Silver; Sulfadiazine | 1975 |
Letter: Silver sulfadiazine adverse effects.
Topics: Burns; Humans; Silver; Sulfadiazine | 1975 |
Prevention of herpes keratoconjunctivitis in rabbits by silver sulfadiazine.
Topics: Animals; Herpes Simplex; Keratoconjunctivitis; Rabbits; Silver; Sulfadiazine | 1975 |
Herpes zoster.
Topics: Female; Herpes Zoster; Humans; Middle Aged; Silver; Skin; Sulfadiazine | 1975 |
Surface-enhanced Raman analysis of sulfa drugs on colloidal silver dispersion.
Topics: Colloids; Microchemistry; Silver; Spectrum Analysis, Raman; Sulfadiazine; Sulfamerazine; Sulfamethazine | 1990 |
[Serum and tissue silver levels after burns treated with silver compounds].
Topics: Administration, Topical; Animals; Burns; Kidney; Liver; Rabbits; Silver; Silver Nitrate; Silver Sulfadiazine; Spectrophotometry, Atomic; Sulfadiazine | 1989 |
A new method for the direct incorporation of antibiotic in prosthetic vascular grafts.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Blood Vessel Prosthesis; Cerium; Methods; Norfloxacin; Oxacillin; Polyethylene Terephthalates; Polytetrafluoroethylene; Rats; Rats, Inbred Strains; Silver; Sulfadiazine; Zinc | 1987 |
Topical treatment of burns.
Topics: Anti-Infective Agents, Local; Biguanides; Burns; Drug Synergism; Evaluation Studies as Topic; Humans; Infections; Silver; Sulfadiazine | 1971 |
Local treatment of burns.
Topics: Acetates; Air; Burns; Hot Temperature; Humans; Humidity; Ointments; Pain; Silver; Silver Nitrate; Sulfadiazine; Sulfonamides; Toluene; Wound Infection | 1971 |
Antifungal activity of silver sulphadiazine.
Topics: Antifungal Agents; Candida albicans; Fungi; Humans; Mycoses; Silver; Sulfadiazine | 1973 |
Letter: Activity of silver sulphadiazine against dermatophytes.
Topics: Arthrodermataceae; Culture Media; Dermatomycoses; Epidermophyton; Humans; Microsporum; Silver; Sulfadiazine; Trichophyton | 1974 |
Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa.
Topics: Bacteriological Techniques; Dialysis; DNA, Bacterial; Pseudomonas aeruginosa; Radioisotopes; RNA, Bacterial; Silver; Sucrose; Sulfadiazine; Sulfur Radioisotopes; Time Factors | 1973 |
Deoxyribonucleic acid repair replication in Pseudomonas aeruginosa after sublethal doses of silver sulfadiazine.
Topics: Carbon Isotopes; Carbon Radioisotopes; Cell Survival; Centrifugation, Density Gradient; Deuterium; DNA Repair; DNA Replication; DNA, Bacterial; Nitrogen Isotopes; Pseudomonas aeruginosa; Radiation Effects; Radioisotopes; Silver; Sulfadiazine; Thymine; Tritium; Ultraviolet Rays | 1973 |
Parenteral nutrition in the burned child: a study of twenty-six patients.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Body Surface Area; Body Weight; Burns; Catheterization; Child; Child, Preschool; Female; Gentamicins; Humans; Infant; Infusions, Parenteral; Parenteral Nutrition; Silver; Skin Transplantation; Sulfadiazine; Sulfonamides; Thrombophlebitis; Transplantation, Autologous; Transplantation, Homologous | 1974 |
Silver sulfadiazine: effect on the ultrastructure of Pseudomonas aeruginosa.
Topics: Microscopy, Electron; Pseudomonas aeruginosa; Silver; Sulfadiazine | 1973 |
Evaluation of topical povidone-iodine ointment in experimental burn wound sepsis.
Topics: Animals; Autopsy; Biopsy; Burns; Evaluation Studies as Topic; Liver; Lung; Male; Povidone; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Silver; Spleen; Sulfadiazine; Sulfonamides; Time Factors; Tosyl Compounds; Virulence; Wound Infection | 1974 |
Experimental burn wound sepsis--evaluation of enzymatic debridement.
Topics: Animals; Bacillus subtilis; Burns; Debridement; Drug Evaluation; Drug Therapy, Combination; Endopeptidases; Male; Methods; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Silver; Subtilisins; Sulfadiazine; Sulfonamides; Swine; Tosyl Compounds; Virulence; Wound Infection | 1974 |
[Effect of collagenase on the necrolysis of burn wounds delayed by antibiotic therapy].
Topics: Animals; Burns; Microbial Collagenase; Necrosis; Silver; Silver Nitrate; Sulfadiazine; Sulfanilamides; Swine; Wound Healing | 1972 |
Antiviral activities of silver sulfadiazine in ocular infection.
Topics: Animals; Antiviral Agents; Cell Line; Cornea; Cricetinae; DNA; Eye Diseases; Humans; Keratitis, Dendritic; Kidney; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Silver; Simplexvirus; Sulfadiazine; Thymidine; Tritium; Vesicular stomatitis Indiana virus; Virus Diseases; Virus Replication | 1974 |
Evaluation of a new topical agent for burn therapy. Silver sulfadiazine (silvadene).
Topics: Administration, Topical; Bacteria; Bacterial Infections; Burns; Drug Evaluation; Drug Resistance, Microbial; Drug Tolerance; Humans; Mutation; Silver; Sulfadiazine; Wound Infection | 1974 |
Burns - a case history.
Topics: Adult; Burns; Humans; Hydrotherapy; Male; Patient Isolators; Physical Therapy Modalities; Silver; Sulfadiazine | 1974 |
Topical therapy of burns in children with silver sulfadiazine.
Topics: Adolescent; Burns; Child; Child, Preschool; Humans; Infant; Ointments; Silver; Sulfadiazine; Time Factors | 1973 |
Delayed primary excision and skin grafting of the burned hand.
Topics: Bacteria; Burns; Granulation Tissue; Hand Injuries; Humans; Occlusive Dressings; Postoperative Care; Silver; Skin Transplantation; Splints; Sulfadiazine; Time Factors; Transplantation, Autologous; Wound Healing | 1973 |
Silver sulfadiazine: effect on the growth and metabolism of bacteria.
Topics: Bacteria; Escherichia coli; Pseudomonas; Silver; Sulfadiazine; Tritium | 1972 |
Use of silver sulphadiazine in the treatment of burns at Royal Perth Hospital.
Topics: Adult; Burns; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Skin Transplantation; Sulfadiazine; Transplantation, Autologous | 1972 |
On the mode of action of silver sulfadiazine.
Topics: Aspartic Acid; Bacterial Proteins; Carbon Isotopes; Cell-Free System; Centrifugation, Density Gradient; Deoxyribonucleases; DNA Nucleotidyltransferases; DNA Replication; DNA, Bacterial; Nucleic Acid Denaturation; Protein Binding; Pseudomonas aeruginosa; Ribosomes; RNA, Bacterial; Silver; Spectrophotometry; Stereoisomerism; Sulfadiazine; Thymidine; Tritium; Uracil | 1972 |
Silver sulfadiazine: interaction with isolated deoxyribonucleic acid.
Topics: Animals; Cattle; Centrifugation, Density Gradient; Cesium; DNA; Silver; Sucrose; Sulfadiazine; Thymus Gland | 1972 |
Effect of skin dressings and topical antibiotics on healing of partial thickness skin wounds in rats.
Topics: Animals; Anti-Bacterial Agents; Female; Occlusive Dressings; Ointments; Rats; Silver; Skin; Staphylococcal Infections; Sulfadiazine; Sulfonamides; Swine; Tosyl Compounds; Wound Healing; Wound Infection | 1973 |
Silver sulfadiazine: in vitro antibacterial activity.
Topics: Bacteria; Microbial Sensitivity Tests; Silver; Sulfadiazine | 1973 |
Silver sulfadiazine: effect on the growth and ultrastructure of Staphylococci.
Topics: Anti-Bacterial Agents; Cell Membrane; Cell Wall; Drug Resistance, Microbial; Microbial Sensitivity Tests; Microscopy, Electron; Silver; Staphylococcus; Sulfadiazine | 1973 |
Sliver sulfadiazine.
Topics: Anti-Infective Agents, Local; Burns; Humans; Silver; Sulfadiazine; Wound Infection | 1974 |
Properties of silver sulfadiazine-resistant Enterobacter cloacae.
Topics: Cell Wall; Cross Reactions; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Microbial Sensitivity Tests; Silver; Sulfadiazine | 1974 |
Care of the burned hand.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bandages; Burns; Gloves, Surgical; Hand Injuries; Humans; Male; Middle Aged; Physical Therapy Modalities; Silver; Splints; Sulfadiazine; Wound Healing | 1974 |
Characterization of silver sulfadiazine and related compounds.
Topics: Ammonia; Crystallization; Deuterium; Indicators and Reagents; Magnetic Resonance Spectroscopy; Morpholines; Pyridines; Silver; Spectrophotometry, Infrared; Sulfadiazine; Sulfamethazine; Sulfanilamides | 1974 |
Virulence of Pseudomonas infection in burned rats and mice. Comparative efficacy of silver sulfadiazine and mafenide.
Topics: Animals; Burns; Culture Techniques; Heart; Mice; Ointments; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Silver; Species Specificity; Sulfadiazine; Sulfonamides; Toluene; Virulence | 1970 |
Characterization of silver deposits in tissue resulting from dermal application of a silver-containing pharmaceutical.
Topics: Animals; Chromatography, Thin Layer; Kidney; Microchemistry; Rabbits; Salts; Silver; Skin Absorption; Solubility; Solvents; Sulfadiazine | 1972 |
Panel discussion: some thoughts on the care of the burned patient, 1972.
Topics: Bacterial Infections; Bandages; Burns; Gentamicins; Humans; Physical Therapy Modalities; Silver; Silver Nitrate; Sulfadiazine; Sulfonamides; Toluene; Wound Healing | 1972 |
Chlorhexidine with silver-sulphadiazine in the treatment of burns.
Topics: Anti-Infective Agents, Local; Biguanides; Burns; Drug Synergism; Humans; Silver; Sulfadiazine | 1971 |
Effect of silver lactate and silver sulfadiazine on experimental burn wound sepsis.
Topics: Allantoin; Animals; Burns; Lactates; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis; Silver; Skin; Sulfadiazine; Sulfonamides; Wound Infection | 1971 |
Silver sulfadiazine cream in the management of burns.
Topics: Adult; Anti-Infective Agents, Local; Burns; Child; Female; Humans; Male; Ointments; Silver; Sulfadiazine | 1970 |
Possible deleterious effects of topical agents on the rate of healing on the burn wound.
Topics: Acetates; Air; Animals; Burns; Dermatologic Agents; Guinea Pigs; Occlusive Dressings; Regeneration; Silver; Sulfadiazine; Sulfonamides; Wound Healing; Wound Infection | 1969 |
Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns.
Topics: Aminobenzoates; Animals; Anti-Infective Agents, Local; Burns; Humans; Mice; Nitrobenzenes; Ointments; Pseudomonas Infections; Silver; Silver Nitrate; Sodium Chloride; Sulfadiazine; Sulfonamides | 1968 |
Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns.
Topics: Adult; Animals; Anti-Infective Agents, Local; Burns; Child; Female; Humans; Male; Mice; Military Medicine; Pseudomonas Infections; Silver; Skin Diseases, Infectious; Sulfadiazine | 1969 |
Control of pseudomonas infection in burns by silver sulfadiazine.
Topics: Adult; Animals; Burns; Cephalothin; DNA; DNA, Bacterial; Female; Guinea Pigs; Humans; Mice; Military Medicine; New York; Ointments; Protein Binding; Pseudomonas Infections; Silver; Sulfadiazine; Vietnam | 1969 |
Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
Topics: Administration, Topical; Animals; Burns; Drug Resistance, Microbial; Female; In Vitro Techniques; Mice; Nalidixic Acid; Norfloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Salts; Silver; Silver Sulfadiazine; Sulfadiazine; Wound Infection | 1981 |
Control of burn wound infections by pefloxacin and its silver derivative.
Topics: Administration, Topical; Animals; Body Weight; Burns; Female; Mice; Nalidixic Acid; Pefloxacin; Pseudomonas Infections; Rats; Silver; Sulfadiazine; Time Factors; Tissue Distribution | 1984 |
[Determination of silver and cerium in the liver and the kidney from a severely burned infant treated with silver sulfadiazine and cerium nitrate].
Topics: Anti-Infective Agents, Local; Burns; Cerium; Humans; Infant; Kidney; Liver; Male; Neutron Activation Analysis; Silver; Silver Sulfadiazine; Sulfadiazine | 1983 |
Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing.
Topics: Animals; Burns; Dermatologic Agents; Microbial Sensitivity Tests; Occlusive Dressings; Ointments; Rats; Silver; Silver Sulfadiazine; Sulfadiazine; Wound Infection | 1981 |
Prevention of bacterial colonization of intravenous catheters by antiseptic impregnation of polyurethane polymers.
Topics: Animals; Anti-Infective Agents, Local; Bacterial Adhesion; Bacterial Infections; Catheterization, Central Venous; Chlorhexidine; Jugular Veins; Male; Polyurethanes; Rats; Rats, Sprague-Dawley; Silver; Staphylococcal Infections; Staphylococcus epidermidis; Sulfadiazine | 1994 |
Interleukin-2 and interleukin-6 in relation to burn wound size in the acute phase of thermal injury.
Topics: Acute Disease; Adult; Age Factors; Aged; Blast Injuries; Burns; Burns, Chemical; Cytokines; Electric Injuries; Female; Humans; Interleukin-2; Interleukin-6; Male; Middle Aged; Silver; Sulfadiazine | 1994 |
A novel chemiluminescence quenching method for determination of sulfonamides in pharmaceutical and biological fluid based on luminol-Ag(III) complex reaction in alkaline solution.
Topics: Anti-Infective Agents; Humans; Luminescent Measurements; Luminol; Silver; Sulfadiazine; Sulfadimethoxine; Sulfameter | 2011 |
Biocompatibility of silver containing silica films on Bioverit® II middle ear prostheses in rabbits.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cell Survival; Ceramics; Coated Materials, Biocompatible; Drug Delivery Systems; Ear, Middle; Male; Mice; NIH 3T3 Cells; Ossicular Prosthesis; Rabbits; Silicon Dioxide; Silver; Sulfadiazine | 2015 |
Solid-state encapsulation of Ag and sulfadiazine on zeolite Y carrier.
Topics: Anti-Bacterial Agents; Capsules; Drug Carriers; Microscopy, Electrochemical, Scanning; Silver; Sulfadiazine; Zeolites | 2015 |
Poly(ethylene glycol)-Based Hyperbranched Polymer from RAFT and Its Application as a Silver-Sulfadiazine-Loaded Antibacterial Hydrogel in Wound Care.
Topics: Anti-Bacterial Agents; Humans; Hydrogels; Polyethylene Glycols; Silver; Sulfadiazine | 2016 |
Indirect spectrophotometric determination of sulfadiazine based on localized surface plasmon resonance peak of silver nanoparticles after cloud point extraction.
Topics: Animals; Dosage Forms; Drinking Water; Humans; Limit of Detection; Linear Models; Metal Nanoparticles; Milk; Reproducibility of Results; Silver; Spectrophotometry; Sulfadiazine; Surface Plasmon Resonance | 2017 |
Interaction of caffeine and sulfadiazine with lysozyme adsorbed at colloidal metal nanoparticle interface: influence on drug transport ability and antibacterial activity.
Topics: Algorithms; Anti-Bacterial Agents; Caffeine; Colloids; Drug Carriers; Enzymes, Immobilized; Gold; Metal Nanoparticles; Models, Theoretical; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Muramidase; Silver; Sulfadiazine; Temperature; Thermodynamics | 2019 |
Galvanic displacement-induced codeposition of reduced-graphene-oxide/silver on alloy fibers for non-destructive SPME@SERS analysis of antibiotics.
Topics: Alloys; Anti-Bacterial Agents; Biosensing Techniques; Copper; Electron Transport; Graphite; Limit of Detection; Metal Nanoparticles; Nanofibers; Oxidation-Reduction; Particle Size; Silver; Solid Phase Microextraction; Spectrum Analysis, Raman; Sulfadiazine; Sulfamethoxazole; Surface Properties | 2018 |
Non-Propellant Foams of Green Nano-Silver and Sulfadiazine: Development and In Vivo Evaluation for Burn Wounds.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Burns; Drug Compounding; Drug Therapy, Combination; Emulsions; Escherichia coli; Green Chemistry Technology; Humans; Male; Metal Nanoparticles; Mice; Oils; Particle Size; Permeability; Silver; Skin; Staphylococcus aureus; Sulfadiazine; Surface-Active Agents; Wound Healing | 2019 |
Selective fluorometric determination of sulfadiazine based on the growth of silver nanoparticles on graphene quantum dots.
Topics: Anti-Bacterial Agents; Fluorometry; Graphite; Metal Nanoparticles; Particle Size; Quantum Dots; Silver; Sulfadiazine; Surface Properties | 2019 |
Co-delivery of superfine nano-silver and solubilized sulfadiazine for enhanced antibacterial functions.
Topics: Anti-Bacterial Agents; Calorimetry, Differential Scanning; Drug Liberation; Escherichia coli; gamma-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Metal Nanoparticles; Metal-Organic Frameworks; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Particle Size; Powder Diffraction; Silver; Solubility; Staphylococcus aureus; Sulfadiazine | 2020 |
High silver concentrations in biological samples following different exposures: Two case reports.
Topics: Burns; Female; Humans; Metal Nanoparticles; Silver; Silver Sulfadiazine; Sulfadiazine | 2021 |
Harnessing biocompatible nanofibers and silver nanoparticles for wound healing: Sandwich wound dressing versus commercial silver sulfadiazine dressing.
Topics: Animals; Anti-Bacterial Agents; Bandages; Metal Nanoparticles; Mice; Nanofibers; Silver; Silver Sulfadiazine; Sulfadiazine; Wound Healing | 2021 |
Antibacterial activity, quality and stability study of creams with new potential silver(I) complexes and
Topics: Amides; Animals; Anti-Bacterial Agents; Silver; Staphylococcus aureus; Sulfadiazine | 2023 |